Cutaneous Rhizopus infection at a central venous catheter site in a critically ill renal transplant patient

Article

<< Previous

Next >>

Contents Vol 17(3)

doi:10.1071/HI12011

Official Journal of the Australasian College for Infection Prevention and Control

	Search




	Advanced Search



	Journal Home

	About the Journal

	Editorial Committee

	Contacts



	Content

	Online Early

	Current Issue

	Just Accepted

	All Issues

	Special Issues

	Sample Issue



	For Authors

	General Information

	Guidelines for Authors

	Submit Article



	For Referees

	Referee Guidelines

	Review Article

	Annual Referee Index



	For Subscribers

	Subscription Prices

	Customer Service

	Print Publication Dates



	For Advertisers

e-Alerts

Subscribe to our Email Alert or

feeds for the latest journal papers.

Connect with us

Submit Article

Use the online submission system to send us your paper.

Cutaneous Rhizopus infection at a central venous catheter site in a critically ill renal transplant patient

Zoel A. Quiñónez ^A, John T. Speicher ^A, Christian Sebat ^B ^C ^D and Mark Avdalovic ^B ^C

^A Department of Anesthesiology and Pain Medicine, University of California Davis Health System, Sacramento, CA 95817, USA.
^B Department of Internal Medicine, Division of Pulmonary, Critical Care and Sleep Medicine, University of California Davis Health System, Sacramento, CA 95817, USA.
^C Department of Internal Medicine, Division of Pulmonary, Critical Care and Sleep Medicine, Mather VA Medical Center (NCHCS), Mather, CA 95655, USA.
^D Corresponding author. Email: csebat@ucdavis.edu

Healthcare Infection 17(3) 83-86 http://dx.doi.org/10.1071/HI12011
Submitted: 13 March 2012 Accepted: 19 June 2012 Published: 16 July 2012





	PDF (97 KB) $25



	Export Citation

Print

Abstract

Invasive fungal infections are increasing in incidence, along with the use of immunosuppressive medications for the prevention of organ transplant rejection, graft versus host disease and treatment of auto-immune disorders. Additionally, the incidence of invasive fungal infections is increasing with the use of new antineoplastic therapies for malignancy, increasing incidence of diabetes mellitus, expanded use of broad-spectrum antimicrobial therapy and with an aging population with chronic medical problems such as chronic renal failure, chronic obstructive pulmonary disease and HIV. We present a case of primary cutaneous zygomycosis at the insertion site of a central venous catheter in a 45-year-old renal transplant patient admitted for acute pancreatitis. In the critical care setting, clinicians must retain a high index of suspicion for invasive fungal infections in immunocompromised individuals to ensure early diagnosis and provide aggressive medical and surgical intervention. Liposomal amphoterin B is the first line antimicrobial therapy, and reduction or discontinuation of immunosuppressive therapy should be considered. Currently there are no consensus opinions or recommendations for routine, scheduled replacement of central venous catheters to prevent infections, even in immunosuppressed patients.

References

[1] Skiada A, Petrikkos G. Cutaneous zygomycosis. Clin Microbiol Infect 2009; 15: 41–5.
| CrossRef |

[2] Roden MM, Zaoutis TE, Buchanan WL, Knudsen TA, Sarkisova TA, Schaufele RL, et al Epidemiology and outcome of zygomycosis: A Review of 929 Reported Cases. Clin Infect Dis 2005; 41: 634–53.
| CrossRef |

[3] Cuenca-Estrella M, Bernal-Martinez L, Isla G, Gomez-Lopez A, Alcazar-Fuoli L, Buitrago MJ. Incidence of zygomycosis in transplant recipients. Clin Microbiol Infect 2009; 15: 37–40.
| CrossRef |

[4] Pak J, Tucci VT, Vincent AL, Sandin RL, Greene JN. Mucormycosis in immunochallenged patients. J Emerg Trauma Shock 2008; 1: 106–13.
| CrossRef |

[5] Almyroudis NG, Sutton DA, Linden P, Rinaldi MG, Fung J, Kusne S. Zygomycosis in solid organ transplant recipients in a tertiary transplant center and review of the literature. Am J Transplant 2006; 6: 2365–74.
| CrossRef | CAS |

[6] Chakrabarti S, Chatterjee S, Das A, Panda N, Shivaprakash MR, Kaur A, et al Invasive zygomycosis in India: experience in a tertiary care hospital. Postgrad Med J 2009; 85: 573–81.
| CrossRef | CAS |

[7] Rüping MJ, Heinz WJ, Kindo AJ, Rickerts V, Lass-Florl C, Beisel C, et al Forty-one recent cases of invasive zygomycosis from global clinical registry. J Antimicrob Chemother 2010; 65: 296–302.
| CrossRef |

[8] Ibrahim AS, Gebremariam T, Fu Y, Edwards JE, Spellberg B. Combination echinocandin-polyene treatment of murine mucormycosis. Antimicrob Agents Chemother 2008; 52: 1556–8.
| CrossRef | CAS |

[9] Greenberg RN, Mullane K, van Burik JA, Raad I, Abzug MJ, Anstead G, et al Posaconazole as salvage therapy in zygomycosis. Antimicrob Agents Chemother 2006; 50: 126–33.
| CrossRef | CAS |

[10] van Burik JA, Hare RS, Solomon HF, Corrado ML, Kontoyiannis DP. Posaconazole is effective as salvage therapy in zygomycosis: a retrospective summary of 91 cases. Clin Infect Dis 2006; 42: e61–5.
| CrossRef | CAS |

[11] Rogers TR. Treatment of zygomycosis: current and new options. J Antimicrob Chemother 2008; 61: i35–i40.
| CrossRef | CAS |

[12] Almyroudis NG, Sutton DA, Fothergill AW, Rinaldi MG, Kusne S. In vitro susceptibilities of 217 clinical isolates of zygomycetes to conventional and new antifungal agents. Antimicrob Agents Chemother 2007; 51: 2587–90.
| CrossRef | CAS |

[13] Cook D, Randolph A, Kernerman P, Cupido C, King D, Soukup C, et al Central venous catheter replacement strategies: A systematic review of the literature. Crit Care Med 1997; 25: 1417–24.
| CrossRef | CAS |

[14] Timsit MJ. Scheduled replacement of central venous catheters is not necessary. Infect Control Hosp Epidemiol 2000; 21: 371–4.
| CrossRef | CAS |

[15] O’Grady NP, Alexander M, Dellinger EP, Gerberding JL, Heard SO, Maki DG, et al Guidelines for the prevention of intravascular catheter-related infections. Infect Control Hosp Epidemiol 2002; 23: 759–69.
| CrossRef |

[16] Safdar N, Kluger DM, Maki DG. A review of risk factors for catheter-related bloodstream infection caused by percutaneously inserted, noncuffed central venous catheters. Medicine 2002; 81: 466–79.
| CrossRef |

[17] Pearson ML, Guidelines for the Hospital Infection Control Practices Advisory Committee Guideline for the prevention of intravascular-device-related infections. Infect Control Hosp Epidemiol 1996; 17: 438–73.
| CrossRef | CAS |

[18] Bach A, Stubbig K, Geiss H. Infectious risk of replacing venous catheters by the guide-wire technique. Zentralbl Hyg Umweltmed 1992; 193: 150–9.
| CAS |

Subscriber Login

	Username: Password:

Legal & Privacy | Contact Us | Help